申请人:Dinnell Kevin
公开号:US20110028486A1
公开(公告)日:2011-02-03
The present invention relates to modulation of the α7 nicotinic acetylcholine receptor (nAChR) by a compound of List A or a salt thereof, which may be represented, but is not limited to the compound N-[(2-Trifluoromethyl-1H-indol-5-yl)methyl]-5-(trifluoromethyl)-2-pyrimidinecarboxamide.
本发明涉及使用List A中的化合物或其盐对α7尼古丁乙酰胆碱受体(nAChR)进行调节,该化合物可以表示为但不限于化合物N-[(2-Trifluoromethyl-1H-indol-5-yl)methyl]-5-(trifluoromethyl)-2-pyrimidinecarboxamide。